EE99: EUROpean Ewing tumour working initiative of national groups - Ewing tumour studies 1999
Chief Investigator:
|
Bernadette Brennan |
| Sponsor: |
University of Birmingham |
| Funder: |
CTAAC |
| Disease Site: |
Sarcoma |
| Trial Type: |
Clinical Trial of an Investigational Medicinal Product |
| Status: |
Closed |
| UKCRN Study ID (if applicable): |
1070 |
| ISRCTN Referance Number: |
61438620 |
| Open to New Sites? |
No |
| Recruitment Start Date: |
09-May-2000 |
| Recruitment End Date: |
03-Mar-2014 |
| CRCTU Trial Management Team: |
CCTT |
| Trial Email Address: |
ee99@trials.bham.ac.uk |
Trial Summary
This trial is closed.
This trial is looking at chemotherapy, surgery and radiotherapy for children, young people and adults with Ewing’s sarcoma or primitive neuroectodermal tumour (PNET). Ewing's sarcoma and peripheral Primitive Neuroectodermal Tumour (PNET) are similar types of cancer mostly affecting teenagers, young adults and children. These cancers mainly develop in or near the bones. Ewing's sarcoma and PNET are usually treated with chemotherapy first. This is usually followed by surgery, radiotherapy and further chemotherapy, or a combination of these. This trials compares several different combinations of chemotherapy drugs to see if they are more effective or have fewer side effects than the standard treatments normally used.
This trial is supported by Cancer Research UK.
Please note that the trials team cannot give individual’s clinical advice. Patients and their families should contact their treating physician to discuss trials.
Trial Protocol
Please Note:
This trial has now closed to recruitment.